Why Kymera Therapeutics Stock Popped This Week: Key Moves
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
What Are Target Date Funds Retirement introduces target date funds, explaining how age-based allocations can simplify retirement investing.
19,788 articlesA flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Analysts lift Occidental targets to as high as $69, citing Permian efficiency and robust cash flow. Oil near $75 prov...
Investors are weighing the risks and potential rewards as Netflix prepares for its July earnings. This guide breaks d...
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
Barclays slashed Molson Coors' price target to $40, underscoring earnings headwinds as the brewer anticipates a tough...
A hedge-fund short report rattled Bloom Energy, triggering a brief stock drop before a swift rebound. Investors are w...
In 2026, savvy investors favor dividend stocks that reliably pay and grow. This article highlights two no-brainer div...
As tesla heads into july, the market faces a tug-of-war: robust quarterly deliveries versus pressure on margins and a...
Bitcoin has endured bear markets and hype cycles alike, and its leadership shows in more than price. Here are four en...
Upstart stock has taken a hard one-way trip downward, leaving some investors wondering if a rebound is possible. This...
Cardano’s May 29 hard fork vote is unfolding as a practical test of governance and DeFi activity. Key infrastructure ...